微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2.01% | -72.73% | 246.55% | 93/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 0.58% | -86.79% | 9.43% | 99/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.53% | -80.15% | -92.9% | 98/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 7.47% | -8.23% | 1.36% | 44/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 7.37% | -10.99% | 67.88% | 46/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.39% | -5.18% | 64.42% | 45/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.67% | -16.04% | -67.2% | 43/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 8.14% | -28.03% | -1.69% | 41/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.28% | -25.41% | 78.83% | 35/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 4.63% | -12.14% | 45.6% | 46/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.18% | -7.83% | -71.88% | 32/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 11.31% | -22.59% | 1.89% | 36/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 11.1% | -5.53% | 110.63% | 26/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 5.27% | -24.39% | 52.75% | 45/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.45% | 3.29% | -76.39% | 27/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 14.61% | 27.93% | 24.34% | 22/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 11.75% | 32.32% | 68.58% | 24/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 6.97% | 34.04% | 108.68% | 31/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.34% | 30.47% | -70.75% | 33/158 | 2.47% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 11.42% | -4.19% | 28.6% | 45/158 | 3.66% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 8.88% | 28.32% | 70.77% | 41/158 | 3.07% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.2% | 2% | 103.13% | 53/158 | 4.23% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.56% | 31.96% | -78.52% | 41/158 | 2.2% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 11.92% | -20% | 72.25% | 42/158 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 6.92% | 2% | 256.7% | 52/158 | 7.53% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 1.94% | 2% | -86.98% | 57/158 | 2.43% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 14.9% | 37.2% | 37.2% | 33/158 | 7.17% | 宏源药业 | 21.91% | 行业排名> |
| 2017-12-31 | 10.86% | 62.82% | 62.82% | 44/158 | 9.68% | 奥赛康 | 9.7% | 行业排名> |
| 2016-12-31 | 6.67% | 2% | 2% | 72/158 | 6.22% | 奥赛康 | 40.69% | 行业排名> |